Goldman Sachs Group Inc

Filing Details

13F-HR/A2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-16
Total Holdings
11,314
Total Value
470725650026
Accession Number
0000769993-25-000301
Form Type
13F-HR/A
Manager Name
Goldman Sachs Group Inc
Data Enrichment
86% identified
9,763 identified1,551 unidentified

Holdings

11,314 positions
Manager:
Search and click to pin securities to the top
Page 239 of 253
Kezar Life Sciences, Inc.
Shares:
28178(-46.1%)
Value:
$137.5M(-60.9%)
STEM, INC.
Shares:
392181(-35.9%)
Value:
$137.4M(-62.8%)
Agora, Inc.
Shares:
33796(+0.0%)
Value:
$135.9M(-3.4%)
MAMMOTH ENERGY SERVICES, INC.
Shares:
66588(-25.6%)
Value:
$135.8M(-49.4%)
Quest Resource Holding Corp
Shares:
51990(+22.8%)
Value:
$135.2M(-50.9%)
ATAI Life Sciences N.V.
Shares:
98641(-42.5%)
Value:
$134.2M(-41.2%)
91854V206
Shares:
24719(-6.3%)
Value:
$133.0M(+2.9%)
G2952X146
Shares:
113608
Value:
$132.9M
Oncology Institute, Inc.
Shares:
115140
Value:
$131.3M
Caesarstone Ltd.
Shares:
53860(-36.4%)
Value:
$130.9M(-63.7%)
Traeger, Inc.
Shares:
76999(-24.6%)
Value:
$129.4M(-47.0%)
Lucid Diagnostics Inc.
Shares:
86302(+35.7%)
Value:
$128.6M(+147.1%)
BlackRock TCP Capital Corp.
Shares:
16006(+4.0%)
Value:
$128.2M(-4.3%)
ATOSSA THERAPEUTICS, INC.
Shares:
187927(-45.5%)
Value:
$126.5M(-61.1%)
Outlook Therapeutics, Inc.
Shares:
103524(+74.1%)
Value:
$126.3M(+12.4%)
Nine Energy Service, Inc.
Shares:
111690(-10.4%)
Value:
$126.2M(-9.6%)
Artiva Biotherapeutics, Inc.
Shares:
41952(+10.2%)
Value:
$125.9M(-67.2%)
Osisko Development Corp.
Shares:
84451(-0.0%)
Value:
$125.8M(-8.6%)
SAGA COMMUNICATIONS INC
Shares:
10024(-1.3%)
Value:
$125.0M(+11.6%)
GYRE THERAPEUTICS, INC.
Shares:
16147(-38.8%)
Value:
$124.7M(-61.0%)